Document is current
Any future updates will be listed below
-
Authors
Bigelow, Amee M. https://orcid.org/0000-0003-1606-9144
Riggs, Kyle W.
Morales, David L. S.
Opotowsky, Alexander R.
Lubert, Adam M.
Dillman, Jonathan R.
Veldtman, Gruschen R.
Heydarian, Haleh C.
Trout, Andrew T.
Cooper, David S.
Goldstein, Stuart L.
Chin, Clifford
Palermo, Joseph J.
Ollberding, Nicholas J.
Mays, Wayne A.
Alsaied, Tarek
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04297241 at ClinicalTrials.govDocuments that mention this clinical trial
Isosorbide DiNitrate Effect on Hemodynamic Profile, Liver Stiffness, and Exercise Tolerance in Fontan Circulation (The NEET Clinical Trial)
https://doi.org/10.1007/s00246-023-03156-3
- License Information
-
More Information
Article History
Received: 4 January 2023
Accepted: 27 March 2023
First Online: 21 April 2023
Declarations
:
: Dr. David Morales discloses the following: consultant for Berlin Heart, Inc.; proctor, consultant, and member of medical advisory board for Syncardia, Inc.; National PI for 50/50 cc Syncardia Total Artificial Heart FDA Trial; consultant for Medtronic Inc. (HeartWare Division), consultant, educator, proctor for Abbott Medical, Inc. (Thoratec Division), consultant for Peca Graft Inc, consultant for Azyio Inc; consultant for Cormatrix Inc. Dr. Jonathan Dillman discloses the following: grant funding from Canon Medical Solutions, and Siemans Healthineers. Dr. Gruschen Veldtman discloses the follow: Consultant for Mezzion. Dr. Andrew Trout discloses the following: research funding from Canon Medical Solutions. Dr. Clifford Chin discloses the following: consultant for Azurity Pharmaceuticals. Drs. Amee Bigelow, Kyle Riggs, Adam Lubert, Alexander Opotowsky, Haleh Heydarian, David Cooper, Stuart Goldstein, Joseph Palermo, Nicholas Ollberding, and Tarek Alsaied have nothing to disclose. Mr. Wayne Mays has nothing to disclose.
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guidelines on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008, and has been approved by the institutional committee at Cincinnati Children’s Hospital.
